
Half of the 2023 US pharmaceutical launch class missed pre-launch first-year forecasts . That gap is usually explained away as a data problem, a market access problem, or a timing...

Are your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? Join us live at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Wednesday 21st May, to discover how...

Discover how Impetus Digital transformed a multicenter Phase III clinical trial with their innovative virtual solutions.
By Thunicia Moodley

Does pharma have something to learn from Welsh jeans maker Hiut Denim when it comes to focus?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The biosimilars field is about to become very crowded. Here are some Life tips on how to stand out from the herd
The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning...
Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.
Head of Commercial Matt Bolton lays out three key points for getting your pre-launch positioning right in Pharma and healthcare.

Stéphanie Bunten and Lee-Ann Cameron's new agency will be based in London's Shoreditch